Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-25-016869
Filing Date
2025-06-05
Accepted
2025-06-05 16:42:27
Documents
1
Period of Report
2025-06-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 6100
  Complete submission text file 0001127602-25-016869.txt   7508
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Issuer) CIK: 0001878313 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address
Smith Stan (Reporting) CIK: 0001913199 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41455 | Film No.: 251027724